Literature DB >> 210944

Phase II study of dianhydrogalactitol in malignant glioma.

P Espana, P H Wiernik, M D Walker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 210944

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  7 in total

1.  Combined treatment of anaplastic astrocytoma (grade 3-4) with diacetyl-dianhydro-galactitol (DADAG).

Authors:  D Afra; S Kerpel-Fronius; I Szinai; B Kocsis; S Eckhardt
Journal:  J Neurooncol       Date:  1990-02       Impact factor: 4.130

2.  1,2:5,6-dianhydrogalactitol inhibits human glioma cell growth in vivo and in vitro by arresting the cell cycle at G2/M phase.

Authors:  Chun Peng; Xin-Ming Qi; Ling-Ling Miao; Jin Ren
Journal:  Acta Pharmacol Sin       Date:  2017-02-20       Impact factor: 6.150

3.  Randomized trial of radiation therapy (RT) plus dibromodulcitol (DBD) versus RT plus BCNU in high grade astrocytoma.

Authors:  T E Elliott; R P Dinapoli; J R O'Fallon; J E Krook; J D Earle; R F Morton; R Levitt; L K Tschetter; B W Scheithauer; D M Pfeifle; D I Twito; R A Nelimark
Journal:  J Neurooncol       Date:  1997-07       Impact factor: 4.130

4.  In vitro cellular characteristics and survival responses of human astrocytoma clones to chloroethyl-nitrosoureas and dianhydrogalactitol.

Authors:  N H Rubin; C Casartelli; B G Macik; W R Boerwinkle; S C Barranco
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

5.  Effect of a single high dose and repeated small doses of dianhydrogalactitol (DAG; NSC-132313) on rat intestinal mucosa.

Authors:  J Kralovánszky; N Prajda; S Kerpel-Fronius; F Gál; Z Szentirmay
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

6.  Heuristic modeling of drug delivery to malignant brain tumors.

Authors:  V A Levin; C S Patlak; H D Landahl
Journal:  J Pharmacokinet Biopharm       Date:  1980-06

7.  Alkylation by 1,2:5,6-dianhydrogalactitol of deoxyribonucleic acid and guanosine.

Authors:  E Institóris; J Tamás
Journal:  Biochem J       Date:  1980-03-01       Impact factor: 3.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.